Renal Carcinoma
18
5
6
2
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 18 trials
100.0%
+13.5% vs benchmark
11%
2 trials in Phase 3/4
0%
0 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (18)
Study of Olaparib in Metastatic Renal Cell Carcinoma Patients With DNA Repair Gene Mutations
Pre-NEOSHIFT-RCC: Neoadjuvant HIF-Inhibitor Immunotherapy in RCC
Symptomatic and Incidental RCC Detection
Radiofrequency Ablation Multicenter Observational Study in Renal Oncology Patients
Memory-like Natural Killer (NK) Cell Therapy in Patients With Renal Cell Carcinoma or Urothelial Carcinoma
R.E.C.K vs Exparel in Robotic Nephrectomy
Serological Autoantibodies in Early Kidney Cancer Diagnosis and Prognosis: A Multicenter Study
Clinical Evaluation of an Augmented Reality Intraprocedural Needle Guidance Platform for Soft Tissue Biopsy
Comparison of Outcomes of Multiple Platforms for Assisted Robotic-Kidney (COMPAR-K)
A Phase I/II Study of Regorafenib Plus Avelumab in Solid Tumors
Integrative Molecular Characterization Of MiT Family Translocation Renal Cell Carcinomas (IMCOR)
A Phase I Study to Evaluate the Safety, Tolerability and Pharmacokinetics of JS004 in Advanced Solid Tumors
the Efficacy and Safety of LDP in Patients With Urinary and Male Genital Tumors
Minocycline Attenuate Postoperative Cognitive Dysfunction and Delirium
Autologous CAR-T/TCR-T Cell Immunotherapy for Malignancies
The Assessment of the Feasibility of a Home Based Exercise Programme in the Older Patient Following Major Surgery
Robot-Assisted Ultrasound for Thermal Ablative Therapy in Treating Patients With Small Kidney Masses Undergoing Surgery
Study of the Impact of VEGF Polymorphism on the Development of Renal Carcinoma in Renal Transplant Patients